Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
370,000
-
Share change
-
+51,490
-
Total reported value
-
$1,602,000
-
Price per share
-
$4.33
-
Number of holders
-
1
-
Value change
-
+$194,514
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q2 2017
As of 30 Jun 2017 TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 370,000 shares of stock of the company.
Largest 1 holders included Opaleye Management Inc..
This table shows 1 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.